Stefan Loren - Feb 14, 2025 Form 4 Insider Report for Cellectar Biosciences, Inc. (CLRB)

Role
Director
Signature
/s/ Christina Blakley, attorney-in-fact for Stefan Loren
Stock symbol
CLRB
Transactions as of
Feb 14, 2025
Transactions value $
$0
Form type
4
Date filed
2/18/2025, 04:05 PM
Previous filing
Jun 18, 2024
SEC
View on sec.gov

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction CLRB Stock option (right to buy) Award $0 +60K $0.00 60K Feb 14, 2025 Common Stock 60K $0.29 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 This option shall vest in full on February 14, 2026, subject to the reporting person's continued service through the applicable vesting date.